| Revenue from operations | 76,840.49a | 76,518.21a |
| Other income | 2,727.84a | 1,980.49a |
| Total income | 79,568.33a | 78,498.7a |
| Expenses | — | — |
| Cost of materials consumed | -21,772.58a | -20,275.99a |
| Purchases of stock-in-trade and biological assets | -6,063.32a | -9,088.37a |
| Changes in inventories of finished goods, stock-in-trade, work-in-progress, intermediates and biological assets | -588.69a | -358.59a |
| Excise duty | -5,959.49a | -5,581.36a |
| Employee benefits expense | -6,134.35a | -5,736.22a |
| Finance costs | -45.96a | -43.2a |
| Depreciation and amortization expense | -1,816.39a | -1,809.01a |
| Other expenses | -11,245.09a | -10,529.93a |
| Total expenses | -52,448.49a | -52,705.49a |
| Share of profit/(loss) of associates and joint ventures | 27.61a | 49.04a |
| Profit before exceptional items and tax | 27,147.45a | 25,842.25a |
| Exceptional items | -7.57a | 72.87a |
| Profit before tax | 27,139.88a | 25,915.12a |
| Tax expense | — | — |
| Current tax | -6,165.27a | -6,450.9a |
| Deferred tax | -223.25a | -12.5a |
| Profit for the year | 20,751.36a | 19,476.72a |